Recent Acquisitions And Cost Control Will Boost Future Efficiency In Pathology Testing

Shared on01 May 25
Fair value Increased 0.11%

Shared on23 Apr 25
Fair value Increased 0.034%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 1.40%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 0.54%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 0.34%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 0.34%

Shared on19 Mar 25
Fair value Decreased 0.47%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 1.26%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.